Evidence map›Paper›PMID 37235323›Full record

ReviewTropical medicine and infectious disease2023

Alternative Non-Drug Treatment Options of the Most Neglected Parasitic Disease Cutaneous Leishmaniasis: A Narrative Review.

Mohamed A A Orabi, Ahmed A Lahiq, Ahmed Abdullah Al Awadh, Mohammed Merae Alshahrani, Basel A Abdel-Wahab, El-Shaymaa Abdel-Sattar

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Tropical medicine and infectious disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Healing and leishmanicidal activity ofFrontiers in chemistry · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohamed A A OrabiDepartment of Pharmacognosy, College of Pharmacy, Najran University, P.O. Box 1988, Najran 66454, Saudi Arabia.ORCID 0000-0002-4288-6829
Ahmed A LahiqDepartment of Pharmaceutics, College of Pharmacy, Najran University, P.O. Box 1988, Najran 66454, Saudi Arabia.ORCID 0000-0002-2781-6515
Ahmed Abdullah Al AwadhDepartment of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, P.O. Box 1988, Najran 66454, Saudi Arabia.ORCID 0000-0001-5860-530X
Mohammed Merae AlshahraniDepartment of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, P.O. Box 1988, Najran 66454, Saudi Arabia.ORCID 0000-0002-9387-5492
Basel A Abdel-WahabDepartment of Pharmacology, College of Pharmacy, Najran University, P.O. Box 1988, Najran 66454, Saudi Arabia.ORCID 0000-0002-5545-6422
El-Shaymaa Abdel-SattarDepartment of Medical Microbiology and Immunology, Faculty of Pharmacy, South Valley University, Qena 83523, Egypt.

Funding

Deanship of Scientific Research at Najran University, Saudi Arabia NU/RG/MRC/11/4
6 · The paper itself

Abstract

With more than 12 million cases worldwide, leishmaniasis is one of the top 10 neglected tropical diseases. According to the WHO, there are approximately 2 million new cases each year in foci in around 90 countries, of which 1.5 million are cutaneous leishmaniasis (CL). Cutaneous leishmaniasis (CL) is a complex cutaneous condition that is caused by a variety of

Indexed as

cauterization therapycryotherapycutaneous leishmaniasislaser therapyleech therapyphotodynamic therapythermotherapy

Identifiers

PMID37235323
PMCPMC10223966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.